Please enable JavaScript to continue using this application.

Compare $GOSS vs $INKT | Chartloom

Compare

$GOSS vs $INKT

Gossamer Bio Inc · Mink Therapeutics Inc

GOSS

Gossamer Bio Inc

INKT

Mink Therapeutics Inc

Compare $GOSS vs $INKT

Comparing Gossamer Bio Inc and Mink Therapeutics Inc

GOSSGossamer Bio Inc

INKTMink Therapeutics Inc

GOSSGossamer Bio Inc

Market cap

$4.55B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

32.4%

YTD performance

-96.0%

52W performance

-95.2%

FCF yield

-3.6%

INKTMink Therapeutics Inc

Market cap

$53M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-3.6%

52W performance

-26.5%

FCF yield

-12.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GOSS

INKT

Detailed metrics comparison

GOSS

Gossamer Bio Inc

INKT

Mink Therapeutics Inc

Market Cap

GOSS$4.55B

INKT$53M

Enterprise Value

GOSS$4.55B

INKT$45M

Price

GOSS$9.31

INKT$10.72

P/E Ratio

GOSSN/A

INKTN/A

P/S Ratio

GOSS85.41x

INKT0.00x

EV/Sales

GOSS85.32x

INKT0.00x

EV/EBITDA

GOSS0.00x

INKT0.00x

P/B Ratio

GOSS2.26x

INKT9.40x

P/FCF Ratio

GOSSN/A

INKTN/A

EV/FCF

GOSS-27.95x

INKT-6.53x

PEG Ratio

GOSSN/A

INKTN/A

Forward P/E (NTM)

GOSSN/A

INKTN/A

Forward P/S (NTM)

GOSSN/A

INKTN/A

Revenue (TTM)

GOSS$53M

INKT$0

Revenue Growth (YoY)

GOSS32.4%

INKTN/A

Forward Rev Growth

GOSS50.5%

INKT17.6%

Gross Margin (TTM)

GOSS0.0%

INKT0.0%

Operating Margin (TTM)

GOSS0.0%

INKT0.0%

EBITDA Margin (TTM)

GOSS-297.6%

INKT0.0%

Net Margin (TTM)

GOSS-235.0%

INKT0.0%

FCF Margin (TTM)

GOSS-305.2%

INKTN/A

Net Income (TTM)

GOSS$-125M

INKT$-11M

FCF (TTM)

GOSS$-163M

INKT$-7M

EPS (TTM)

GOSS-$0.38

INKT-$2.26

ROE (TTM)

GOSS-11877.0%

INKT-16887.0%

ROA (TTM)

GOSS-8535.0%

INKT-9237.0%

ROIC (TTM)

GOSS-2300.0%

INKT-16887.0%

Cash

GOSS$41M

INKT$9M

Debt

GOSS$36M

INKT$0

Net Cash/Debt

GOSS$5M

INKT$9M

Current Ratio (TTM)

GOSS0.53x

INKT1.23x

Quick Ratio (TTM)

GOSS0.46x

INKT1.19x

Debt/Equity (TTM)

GOSS6.83x

INKT0.00x

Debt/Assets (TTM)

GOSS0.0%

INKT0.0%

Interest Coverage (TTM)

GOSSN/A

INKTN/A

Net Debt/EBITDA (TTM)

GOSS0.00x

INKT0.00x

Beta

GOSS2.28

INKT0.45

52W Performance

GOSS-95.2%

INKT-26.5%

YTD Performance

GOSS-96.0%

INKT-3.6%

% from 52W High

GOSS-97.0%

INKT-36.7%

% from 52W Low

GOSS2.3%

INKT26.4%

Asset Turnover (TTM)

GOSS0.36x

INKT0.00x

FCF Yield (TTM)

GOSS-3.6%

INKT-12.8%

Earnings Yield (TTM)

GOSS-2.8%

INKT-21.3%

Dividend Yield (TTM)

GOSSN/A

INKTN/A

Rule of 40

GOSS-272.8

INKT0.0

EV/GP/RG

GOSSN/A

INKTN/A

Ticker research

View GOSS research View INKT research

Metric	GOSS Gossamer Bio Inc	INKT Mink Therapeutics Inc
Market & Valuation
Market Cap	$4.55B	$53M
Enterprise Value	$4.55B	$45M
Price	$9.31	$10.72
P/E Ratio	N/A	N/A
P/S Ratio	85.41x	0.00x
EV/Sales	85.32x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.26x	9.40x
P/FCF Ratio	N/A	N/A
EV/FCF	-27.95x	-6.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$53M	$0
Revenue Growth (YoY)	32.4%	N/A
Forward Rev Growth	50.5%	17.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-297.6%	0.0%
Net Margin (TTM)	-235.0%	0.0%
FCF Margin (TTM)	-305.2%	N/A
Net Income (TTM)	$-125M	$-11M
FCF (TTM)	$-163M	$-7M
EPS (TTM)	-$0.38	-$2.26
ROE (TTM)	-11877.0%	-16887.0%
ROA (TTM)	-8535.0%	-9237.0%
ROIC (TTM)	-2300.0%	-16887.0%
Financial Health
Cash	$41M	$9M
Debt	$36M	$0
Net Cash/Debt	$5M	$9M
Current Ratio (TTM)	0.53x	1.23x
Quick Ratio (TTM)	0.46x	1.19x
Debt/Equity (TTM)	6.83x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.28	0.45
52W Performance	-95.2%	-26.5%
YTD Performance	-96.0%	-3.6%
% from 52W High	-97.0%	-36.7%
% from 52W Low	2.3%	26.4%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.00x
FCF Yield (TTM)	-3.6%	-12.8%
Earnings Yield (TTM)	-2.8%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-272.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View GOSS research	View INKT research

Valuation

P/S Ratio

INKT

0.00x

GOSS

85.41x

EV/FCF

GOSS

-27.95x

INKT

-6.53x

Growth & revenue

Revenue Growth TTM

GOSS

32.4%

Forward Revenue Growth

GOSS

50.5%

INKT

17.6%

Profitability & performance

Gross Margin

GOSS

0.0%

INKT

0.0%

ROE

GOSS

-11877.0%

INKT

-16887.0%

FCF Yield %

GOSS

-3.6%

INKT

-12.8%

52-Week Performance

INKT

-26.5%

GOSS

-95.2%

Detailed metrics comparison

GOSS

Gossamer Bio Inc

INKT

Mink Therapeutics Inc

Market Cap

GOSS$4.55B

INKT$53M

Enterprise Value

GOSS$4.55B

INKT$45M

Price

GOSS$9.31

INKT$10.72

P/E Ratio

GOSSN/A

INKTN/A

P/S Ratio

GOSS85.41x

INKT0.00x

EV/Sales

GOSS85.32x

INKT0.00x

EV/EBITDA

GOSS0.00x

INKT0.00x

P/B Ratio

GOSS2.26x

INKT9.40x

P/FCF Ratio

GOSSN/A

INKTN/A

EV/FCF

GOSS-27.95x

INKT-6.53x

PEG Ratio

GOSSN/A

INKTN/A

Forward P/E (NTM)

GOSSN/A

INKTN/A

Forward P/S (NTM)

GOSSN/A

INKTN/A

Revenue (TTM)

GOSS$53M

INKT$0

Revenue Growth (YoY)

GOSS32.4%

INKTN/A

Forward Rev Growth

GOSS50.5%

INKT17.6%

Gross Margin (TTM)

GOSS0.0%

INKT0.0%

Operating Margin (TTM)

GOSS0.0%

INKT0.0%

EBITDA Margin (TTM)

GOSS-297.6%

INKT0.0%

Net Margin (TTM)

GOSS-235.0%

INKT0.0%

FCF Margin (TTM)

GOSS-305.2%

INKTN/A

Net Income (TTM)

GOSS$-125M

INKT$-11M

FCF (TTM)

GOSS$-163M

INKT$-7M

EPS (TTM)

GOSS-$0.38

INKT-$2.26

ROE (TTM)

GOSS-11877.0%

INKT-16887.0%

ROA (TTM)

GOSS-8535.0%

INKT-9237.0%

ROIC (TTM)

GOSS-2300.0%

INKT-16887.0%

Cash

GOSS$41M

INKT$9M

Debt

GOSS$36M

INKT$0

Net Cash/Debt

GOSS$5M

INKT$9M

Current Ratio (TTM)

GOSS0.53x

INKT1.23x

Quick Ratio (TTM)

GOSS0.46x

INKT1.19x

Debt/Equity (TTM)

GOSS6.83x

INKT0.00x

Debt/Assets (TTM)

GOSS0.0%

INKT0.0%

Interest Coverage (TTM)

GOSSN/A

INKTN/A

Net Debt/EBITDA (TTM)

GOSS0.00x

INKT0.00x

Beta

GOSS2.28

INKT0.45

52W Performance

GOSS-95.2%

INKT-26.5%

YTD Performance

GOSS-96.0%

INKT-3.6%

% from 52W High

GOSS-97.0%

INKT-36.7%

% from 52W Low

GOSS2.3%

INKT26.4%

Asset Turnover (TTM)

GOSS0.36x

INKT0.00x

FCF Yield (TTM)

GOSS-3.6%

INKT-12.8%

Earnings Yield (TTM)

GOSS-2.8%

INKT-21.3%

Dividend Yield (TTM)

GOSSN/A

INKTN/A

Rule of 40

GOSS-272.8

INKT0.0

EV/GP/RG

GOSSN/A

INKTN/A

Ticker research

View GOSS research View INKT research

Metric	GOSS Gossamer Bio Inc	INKT Mink Therapeutics Inc
Market & Valuation
Market Cap	$4.55B	$53M
Enterprise Value	$4.55B	$45M
Price	$9.31	$10.72
P/E Ratio	N/A	N/A
P/S Ratio	85.41x	0.00x
EV/Sales	85.32x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.26x	9.40x
P/FCF Ratio	N/A	N/A
EV/FCF	-27.95x	-6.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$53M	$0
Revenue Growth (YoY)	32.4%	N/A
Forward Rev Growth	50.5%	17.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-297.6%	0.0%
Net Margin (TTM)	-235.0%	0.0%
FCF Margin (TTM)	-305.2%	N/A
Net Income (TTM)	$-125M	$-11M
FCF (TTM)	$-163M	$-7M
EPS (TTM)	-$0.38	-$2.26
ROE (TTM)	-11877.0%	-16887.0%
ROA (TTM)	-8535.0%	-9237.0%
ROIC (TTM)	-2300.0%	-16887.0%
Financial Health
Cash	$41M	$9M
Debt	$36M	$0
Net Cash/Debt	$5M	$9M
Current Ratio (TTM)	0.53x	1.23x
Quick Ratio (TTM)	0.46x	1.19x
Debt/Equity (TTM)	6.83x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.28	0.45
52W Performance	-95.2%	-26.5%
YTD Performance	-96.0%	-3.6%
% from 52W High	-97.0%	-36.7%
% from 52W Low	2.3%	26.4%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.00x
FCF Yield (TTM)	-3.6%	-12.8%
Earnings Yield (TTM)	-2.8%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-272.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View GOSS research	View INKT research